2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Meperidine: new trials by email Literature Review of Meperidine trials Research Report on Meperidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers IL-2 (Aldesleukin), Cyclophosphamide, KK-LC-1 TCR - Kita-kyushu Lung Cancer Antigen 1, Human | Phase 1 | Terminated | National Cancer Institute (NCI) | 36 | 2022-03-08 | 2025-12-02 |
| E7 TCR T Cells for Human Papillomavirus-Associated Cancers E7 TCR cells, Aldesleukin, Fludarabine - Papillomavirus Infections, Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 224 | 2017-01-27 | 2026-03-09 |
| Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease Diphenhydramine, Acetaminophen, Methylprednisolone - Sickle Cell Disease, Graft Versus Host Disease | Phase 1 | Completed | Monica Bhatia | 24 | 2016-07-01 | 2024-06-13 |
Anemia, Sickle Cell (1) · Carcinoma (1) · Carcinoma in Situ (1) · Graft vs Host Disease (1) · Neoplasm Metastasis (1) · Papillomavirus Infections (1) · Triple Negative Breast Neoplasms (1) · Uterine Cervical Dysplasia (1) · Vulvar Diseases (1) · Vulvar Neoplasms (1)
National Cancer Institute (NCI) (2) · Monica Bhatia (1)
United States (3)
Scott M Norberg, D.O. (2) · Monica Bhatia, MD (1)